MSLPQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MSLPQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. MusclePharm's YoY EBITDA Growth for the quarter that ended in Mar. 2022 was -1,226.67%.
MusclePharm's EBITDA per Share for the three months ended in Mar. 2022 was $-0.17.
The historical data trend for MusclePharm's YoY EBITDA Growth can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MusclePharm Annual Data | |||||||||||||||||||||
Trend | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | |||||||||||
YoY EBITDA Growth | Get a 7-Day Free Trial | -1,077.78 | 9.09 | -76.25 | 118.30 | -329.46 |
MusclePharm Quarterly Data | ||||||||||||||||||||
Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | |
YoY EBITDA Growth | Get a 7-Day Free Trial | -31.82 | -387.50 | -424.14 | -316.25 | -1,226.67 |
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.
MusclePharm's YoY EBITDA Growth for the fiscal year that ended in Dec. 2021 is calculated as:
YoY EBITDA Growth (A: Dec. 2021 ) | |||||
= | (EBITDA per Share (A: Dec. 2021 ) | - | EBITDA per Share (A: Dec. 2020 )) | / | | EBITDA per Share (A: Dec. 2020 ) | |
= | (-0.296 | - | 0.129) | / | | 0.129 | |
= | -329.46 % |
MusclePharm's YoY EBITDA Growth for the quarter that ended in Mar. 2022 is calculated as:
YoY EBITDA Growth (Q: Mar. 2022 ) | |||||
= | (EBITDA per Share (Q: Mar. 2022 ) | - | EBITDA per Share (Q: Mar. 2021 )) | / | | EBITDA per Share (Q: Mar. 2021 )) | |
= | (-0.169 | - | 0.015) | / | | 0.015 | |
= | -1,226.67 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of MusclePharm's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.
Eric Chin | officer: Chief Accounting Officer | 1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801 |
Paul W Karr | director | BRISTOL MEYERS SQUIBB CO, 345 PARK AVENUE, NEW YORK NY 10154 |
Sabina Rizvi | officer: President & CFO | 6728 W. SUNSET ROAD, SUITE 130, LAS VEGAS NV 89118 |
Michael David Heller | director | 4500 PARK GRANADA, SUITE 202, CALABASAS CA 91302 |
Wynnefield Partners Small Cap Value Lp I | 10 percent owner | 450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123 |
Donald Feagan | 10 percent owner | 2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106 |
Amerop Holdings, Inc. | 10 percent owner | 1800 BROADWAY, SUITE 100, BOULDER CO 80302 |
White Winston Select Asset Fund Series Fund Mp-18, Llc | 10 percent owner | C/O WHITE WINSTON SELECT ASSET FUNDS, LLC, 265 FRANKLIN ST., SUITE 1702, BOSTON MA 02110 |
Robert P Mahoney | 10 percent owner | 4 DANIELS FARM ROAD, #305, TRUMBULL CT 06611 |
White Winston Select Asset Funds, Llc | 10 percent owner | 265 FRANKLIN STREET, SUITE 1702, BOSTON MA 02110 |
Todd M. Enright | 10 percent owner | 2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106 |
Mark Blundell | 10 percent owner | 8 MACDONALD AVE, ARMOUK NY 10504 |
John J Desmond | director | 10 GLEN HEAD ROAD, GLEN HEAD NY 11545 |
Wynnefield Small Cap Value Offshore Fund Ltd | 10 percent owner | 450 SEVENTH AVE, STE 509, NEW YORK NY 10123 |
Wynnefield Capital Inc | 10 percent owner | 450 SEVENTH AVE, STE 509, NEW YORK NY 10123 |
From GuruFocus
By Marketwired Marketwired • 06-08-2021
By Don Li2 Don Li2 • 11-10-2021
By Marketwired Marketwired • 08-09-2021
By Marketwired Marketwired • 08-16-2021
By Marketwired Marketwired • 10-29-2021
By ACCESSWIRE AccessWire • 05-06-2019
By GuruFocusNews GuruFocusNews • 03-31-2022
By GuruFocusNews GuruFocusNews • 02-15-2022
By Marketwired Marketwired • 07-26-2021
By Marketwired Marketwired • 05-21-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.